-
Professor Jun Zhu: Focus on the unmet needs of diffuse large B-cell lymphoma (DLBCL) and provide personalized diagnosis and treatment for patients
Diffuse large B-cell lymphoma (DLBCL) is a typical B-cell lymphoma, characterized by high invasiveness and heterogeneity. After standard first-line treatment, some patients still face relapse/refractory issues and relatively poor prognosis. Recently, the “7th Beijing Thrombosis and Hemostasis Conference and the 5th Beijing Hematology Oncology and Immunology Summit Forum” was successfully held in Beijing from March…
-
Professor Hu Zhou: Rational selection of treatment strategies to improve the quality of life for patients with tumor-related thrombocytopenia
Thrombocytopenia is a common hematologic adverse reaction to cancer treatment, which can increase the risk of bleeding, prolong hospitalization, increase medical costs, and in severe cases, lead to death. Recently, the “7th Beijing Thrombosis and Hemostasis Conference and the 5th Beijing Hematology Oncology and Immunology Summit Forum”, hosted by the Chinese Society of Immunology Hematology…
-
Professor Jun Ma: Development in the Field of Hematologic Tumors Advances by Leaps and Bounds, Autonomous Innovation Facilitates the Improvement of Diagnosis and Treatment
The “7th Beijing Thrombosis and Hemostasis Conference of the Chinese Society of Immunology Hematology Branch” and the “5th Beijing Hematologic Tumor and Immunology Summit Forum” sponsored by the Chinese Society of Immunology Hematology Branch and hosted by the National Clinical Research Center for Hematologic Diseases- Peking University Institute of Hematology and Peking Union Medical College…
-
Professor Xiaohui Zhang: From running behind to leading the world in hematopoietic stem cell transplantation in China | The 13th National Conference on Hematopoietic Stem Cell Transplantation of the Chinese Medical Association
As spring arrives, the 13th National Conference on Hematopoietic Stem Cell Transplantation of the Chinese Medical Association, hosted by the Chinese Medical Association and organized by the National Clinical Research Center for Hematologic Diseases-Peking University Institute of Hematology, was grandly held in Beijing from March 1st to 2nd. This conference focused comprehensively on hematopoietic stem…
-
Hematopoietic stem cell heterogeneity in non-human primates revealed by five-lineage output bias analysis
Hematopoietic stem cells (HSCs) are pivotal in maintaining blood cell production, and their diversity in lineage output bias significantly influences hematopoietic processes and therapeutic strategies for blood disorders. This study…
-
Machine Learning Prognostic Model for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation: A Revolutionary Approach Towards Personalized Post-Transplant Care
Haploidentical hematopoietic stem cell transplantation (HSCT) has emerged as a pivotal therapeutic intervention for acute leukemia patients. However, post-transplant complications, particularly Epstein-Barr virus (EBV) reactivation, pose significant risks to patient…
-
Professor Erjie Jiang: Poor Prognosis of Acute Graft-versus-Host Disease, Awaiting More New Drugs to Improve Efficacy | The 13th National Hematopoietic Stem Cell Transplantation Academic Conference of the Chinese Medical Association
Acute graft-versus-host disease (aGVHD) is a severe complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and is a major cause of non-relapse mortality in patients with hematologic malignancies. Although treatment options for aGVHD have advanced in recent years, the prognosis remains poor. Recently, the “13th National Hematopoietic Stem Cell Transplantation Academic Conference of the Chinese…
-
Professor Qifa Liu : Clinical Research Should Focus on Methodology of Study Design and Standardization of Registration | The 13th National Hematopoietic Stem Cell Transplantation Academic Conference of the Chinese Medical Association”
From March 1st to 2nd, 2024, the “13th National Hematopoietic Stem Cell Transplantation Academic Conference of the Chinese Medical Association,” hosted by the Chinese Medical Association and organized by the National Clinical Research Center for Hematologic Diseases – Peking University Institute of Hematology, was grandly held in Beijing. Many renowned experts and scholars in the…
Connecting Medical Expertise through Media